Dutasteride, a 5-alpha reductase inhibitor, treats benign prostate gland enlargement (benign prostatic hyperplasia). Its profound side effect or complication is its ability to increase the risk of developing high-grade prostate cancer. Other adverse effects include erectile dysfunction, ejaculation problems, and loss of sexual desire.
Dutasteride: Shaping the Future of BPH Treatment
Dutasteride is an antiandrogenic drug that is mostly recommended to adult males with symptomatic Benign Prostatic Hyperplasia (BPH).
